Legacy asset
VC Fund
Mumbai, India
Legacy asset is a VC fund in Mumbai focused on Biotechnology and Software. Legacy assets' prominent investment areas include biotech, government, and health tech, as well as investments in startups.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Legacy asset invests in
Stages Legacy asset invests in
Countries Legacy asset invests in
Round sizes
Round size
- Series A
- $2.6M–$11M
Investment Focus
Industry
- Biotechnology 2 (40%)
- Software 1 (20%)
- Education 1 (20%)
- Electronics 1 (20%)
- Health Care 1 (20%)
Stage
- Series A 4 (80%)
- Seed 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Brandworks Technologies
|
Brandworks Technologies is a design-focused, tech-driven firm delivering smart, cost-effective OEM-ODM solutions | $11M / Series A / Aug 12, 2025 | |
Ahammune Biosciences
|
Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. | $5M / Series A / Sep 25, 2024 | |
Mynvax
|
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic.Mynvax, which was incubated at the Indian Institute of Science, was founded in2017 by Raghavan Varadarajan and Gautham Nadig. | $2.6M / Series A / May 24, 2024 | |
Cusmat
|
Cusmat enable organisations to assess, train, upskill, plan learning tracks for employees by using AR/VR cloud learning management systems. | $3.5M / Series A / Feb 07, 2023 | |
|
Ahammune Biosciences
|
Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. | Seed / Apr 26, 2021 |
Co-Investors
Ideaspring Capital
2 deals together
IAN Group
2 deals together
Arkam Ventures
1 deal together
Better Capital
1 deal together
Cactus Partners
1 deal together
Capital 2B
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Legacy asset invest in?
Legacy asset invests primarily in Biotechnology, Software and Education startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Legacy asset's check size?
Legacy asset typically joins rounds of $2.6M–$11M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Legacy asset participates in.
When did Legacy asset last invest?
The most recent investment recorded for Legacy asset closed in Aug 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
